Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Scientists possibly cure HIV in first-time breakthrough for virus

February 16, 2022 Research and Development

An American research team appear to have cured HIV in a woman for the first time, making her the third …
News

Moderna launch Omicron-specific UK vaccine study

February 16, 2022 Research and Development

Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …
News

FDA investigate possible increased risk of death with lymphoma medicine

February 9, 2022 Research and Development

The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …
News

SaNOtize breakthrough treatment 99% effective against COVID-19

February 9, 2022 Research and Development

SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …
News

Despite persistent need, J&J halts COVID-19 vaccine output

February 9, 2022 Research and Development

Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …
News

Novavax submits EUA to FDA for COVID-19 vaccine candidate

February 2, 2022 Research and Development

Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …
News

Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO

February 2, 2022 Research and Development

The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …
News

FDA approval of six-annual-dose HIV treatment

February 2, 2022 Research and Development

ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for
News

First European filing submission for multiple myeloma bispecific antibody

February 2, 2022 Research and Development

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …
News

FDA clearance of Investigational New Drug Application for novel peanut allergy vaccine

January 26, 2022 Research and Development

Allergy Therapeutics has announced the FDA clearance of the Investigational New Drug Application (IND) for its novel virus-like particle (VLP)-based …
News

Highest UK COVID-19 deaths since February as Pfizer begin trials for Omicron jab

January 26, 2022 Research and Development

Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant, and has shared that it …
News

Maxim Biomedical receives EUA for ClearDetect COVID-19 antigen home test

January 26, 2022 Research and Development

Maxim Biomedical have received an Emergency Use Authorisation (EUA) from the FDA for their new ClearDetect COVID-19 Antigen Home Test. …
News

New study highlights cell power as a functional biomarker for preventing tumour escape

January 26, 2022 Research and Development

LUMICKS announced that new research findings published in Translational Medicine detailed a novel design strategy for preventing tumour escape through …
News

Engitix and Dompé collaboration for fibrosis and cancer AI drug discovery

January 19, 2022 Research and Development

Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …
News
e-6olmfwuay74lr

MHRA license Jyseleca for treatment of ulcerative colitis

January 19, 2022 Research and Development

Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026